Dr. Anjali Vaidya Participates in Q&A with Becker’s Hospital Review on Novel Screening Tool Developed at Lewis Katz School of Medicine Which Shows Significant Promise for Improving Detection of Pulmonary Arterial Hypertension

Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of the Advanced Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at Temple University Hospital, participated in a Q&A interview with Becker’s Hospital Review about the novel screening approach developed by physicians at the Lewis Katz School of Medicine at Temple University which shows significant promise for improving the detection of pulmonary arterial hypertension (PAH). The new research, published online April 5 in the American Heart Journal, shows that the virtual echocardiography screening tool (VEST), when incorporated into the electronic medical record (EMR) system, can generate accurate PAH risk scores – without the need for time-consuming manual calculations. The approach is the first of its kind in the field of pulmonary vascular medicine. Dr. Vaidya is the lead author on the study.